AMRN

#979
Amarin Corp Plc
15.3400 USD
-6.29%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
15.3400
15.3400
Intervallo Annuale
13.5100
17.0000
Variazione giornaliera
-6.29%
Variazione Mensile
-1.41%
Variazione di 6 mesi
-1.41%
Variazione Annuale
-1.41%
Chiusura Precedente
16.3700
Open
15.3400
Bid
15.3400
Ask
15.3430
Low
15.3400
High
15.3400
Volume
10
Open full chart

Financials

Overview Estratto Conto Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

Amarin Corporation plc - American Depositary Shares, each repre

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza.

Notizie